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The major envelope glycoprotein of murine  leukemia virus  (MuLV), I gp70, 
occurs on the  thymocytes of several mouse strains  which are not overt virus 
producers (1-3). Gi×-gp70 is a type-specific variant demonstrable by the cytotox- 
icity assay on thymocytes of the prototype G[x  + strain 129, and a number of other 
mouse strains (4). Two congenic mouse stocks have been derived, B6-~x (allele 
donor,  129) and 129-~x- (allele donor, B6), which differ from B6 (Cnx-) and 129 
(Cnx+), respectively, in regard to expression of Cnx-gp70 on their thymocytes (5). 
We call these four strains "the C~x quartet." B6-~x + will be abbreviated as B6  +, 
and 129-G~x- as 129-. 
On thymocytes, Gix is an accessible antigen,  hence its demonstrability in the 
cytotoxicity assay. Group-specific (gs) antigens elsewhere on the gp70 molecule 
are relatively or wholly inaccessible unless the membrane is first disrupted (2). 
Accessibility may be important in determining the consequences of autoimmu- 
nization involving gp70 antigens.  But so far, G~x antibody has never been found 
in normal mouse serum, nor has it been possible to produce it by immunization 
of mice. Description of the G~x system has depended on the well-known antise- 
rum "anti-NTD" prepared in inbred rats  (4). 
We now report that a certain hybrid, the (B6  + ×  129)F1 mouse, spontaneously 
produces G~x antibody. We shall use the abbreviation "F1 serum" in reference to 
any pool of normal sera from these hybrids, selected for high titer against B6  + 
thymocytes with little or no titer against B6 thymocytes. 
Materials  and Methods 
The "two-step" cytotoxicity assay for G[x (1) was used for all tests with the F~ serum, and the 
usual  "one-step"  test  (4),  in  which  the  cells  are  not  presensitized  and  washed  before  adding 
complement (C), was used for all other purposes. The cytotoxicity index (CI) =  (a  -  b)/(100 -  b); 
where a  =  % cells lysed by antiserum and C, and b  =  % cells lysod in the controls with antiserum 
omitted. Results are expressed either as CI, or as "cells lysed %" (= CI  x  100). 
The labeling of viable thymocytes with ~25I by lactoperoxidase, followed by lysis with Nonidet P- 
40 (Shell Chemical Co., New York) immunoprecipitation, and electrophoresis in sodium dodecyl 
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sulfate  polyacrylamide  gel  (SDS-PAGE)  is described  elsewhere  (2).  We  use  the  abbreviation 
"radio-immunoprecipitation (RIP)-lactoperoxidase method" in the text. 
The Ig class of the naturally occurring Gxx antibody in FI serum was determined by affinity 
chromatography (6). An ammonium sulfate precipitate (38% final saturation) of rabbit anti-mouse 
IgM (Litton Bionetics, Inc., Kensington, Md.) was conjugated to Sepharose® 4B activated at pH 
11.2 with CNBr. FI serum was applied to the column and the column was washed with phosphate- 
buffered saline until the OD2so of the effluent was <0.025.  Class specificity was confirmed by con- 
trol tests in which anti(a)-H-2 antibody of the IgG class was not retained. 
Results and Discussion 
I.  G~x Specificity  of Antibody  in  the F~ Serum.  This  is  indicated by the 
positive reaction with B6 ÷ thymocytes in the cytotoxicity assay, as compared 
with the negative or low reaction with B6 thymocytes (Table I). This specificity 
has been confirmed by segregation tests in the backcross  (B6  x  B6 ÷)  x  B6 ÷. 
Thymocytes of these backcross  mice were typed for G~x  conventionally with 
~NTD,  and  also  with  F~  serum;  the  results  were  entirely concordant.  The 
incidence and titer of Gix antibody rise with age (Fig. 1). 
Because the G~x congenic strains differ from their partner strains in expres- 
sion of at least one other virus-coded protein, p30, as well as gp70 (5, 9), possibly 
the specificity of the cytotoxic F~ serum might be related to a viral component 
other than gp70. It is also possible that the antigen recognized by the F~ serum is 
a  feature  of the  GEx-gp70 molecule but  is  not  identical to  G~×. Neither  the 
serological distinctions between the G~x congenic lines (Table I) nor the concord- 
ant segregation data exclude these two possibilities, but the following evidence 
makes them unlikely: (a)  It is  highly characteristic of G~x  identified by the 
standard rat typing serum c~NTD that cytotoxic reactions with the thymocytes 
of G~x  ÷ homozygotes are much higher than with heterozygotes although absorp- 
tion shows precisely 50% expression on the latter (4); the same is true of the F~ 
serum. (b) Of 18 various mouse stocks whose G~x phenotypes have already been 
established conventionally with aNTD  (4)  all give the same typing reactions 
with the  F~  serum,  by both  direct tests  and  absorption.  (c)  14  transplanted 
leukemias and 3 other tumors, 9 G~x  + and 8 G~x- (4), were tested for their ability 
to absorb cytotoxic activity from the F~ serum, the absorbed serum being tested 
against B6 ÷ thymocytes. All the G~× + tumors removed cytotoxic activity from F~ 
serum; none of the G~x- tumors did so. (d) It is typical of Gix that the thymocytes 
of different inbred strains display uniformly different amounts of G~x antigen, 
which greatly influence their sensitivity to c~NTD in the cytotoxicity assay (4). 
Similar differences are  seen in sensitivity to the F~  serum, corresponding to 
published data for the "GIx  3, G1x  2, and Glx  ~'' categories of GIx  + mouse strains (4). 
(e) The tissue representation of the antigen recognized by the F~ serum is the 
same as that of G~x (4); i.e. it is demonstrable on thymocytes but not on spleen 
cells of G~x  + low-virus mice, and on thymocytes, spleen, and lymph node cells of 
high-virus mice like AKR. (f) The serum of 129 mice contains free G~x-gp70 that 
neutralizes the cytotexic activity of aNTD against G~x  + thymocytes (1). The F~ 
serum is also neutralized by 129 serum but not by 129-  serum. Thus by these 
several criteria the F~ serum specificity is identical to G~x in cytotoxicity assays. 
Why is it that of many G~x  ÷ mouse stocks we have tested (Table II), including 
the parents of the  (B6 ÷ x  129) cross,  only this hybrid (with exceptions noted OBATA  ET  AL.  535 
TABLE  I 
Cytotoxicity Assays of Sera from 18 (B6 +  x  129) Hybrid ~ Mice,* 
Selected for High Activity against B6 + Thymocytes  with 
Negligible Activity against B6 Thymocytes 
Mouse strain 
Thymocytes lysed$ by F, serum diluted 1/ 
4  8  16  32  64  128  256 
%  %  %  %  %  %  % 
B6  ÷  94  94  82  65  59  31  9 
B6  12  13  7  4  0  0  0 
* The data are mean readings for the 18 separate titrations. 
CI x  100 (see Materials and Methods). 
;  Number of mice  tested* 
100  14  215  29  32  19 
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tiler 1:52 - h64) 
Fro.  1.  Incidence and titer of natural cytotoxic G~x antibody in the serum of 144 (B6 ÷ x 
129) hybrid mice aged 1-6 mo.  The serum of each mouse was graded by subtracting the 
control, "B6 thymocytes lysed %" (CI × 100), from "B6 + thymocytes lysed %" (CI x 100); this 
allows for the variable and generally low background of cytotoxicity for B6 thymocytes 
attributable to thymocyte autoantibody of unknown specificity (7, 8). 
below) produces appreciable amounts  of aG~x? Control by immune  response (Ir) 
genes  is  a  possible explanation.  To  explain  the  "nonresponder"  status  of the 
parental  B6 ÷ and 129 stocks, two dominant Ir loci can be postulated, affecting B 
and  T  cells,  respectively,  or two  functionally  different T-cell subclasses.  Both 
would  be  required  for the  "G~x  responder"  phenotype,  and  each  parent  would 
contribute one of the two genes to the hybrid. Thus  Gix autoimmunization  may 
constitute  a  natural  example  of experiments  in  which  matings  between  mice 
that are nonresponsive to certain antigens  yield responsive progeny (10,  11). 
The control hybrid  (B6  x  129-)  is genetically identical to (B6 ÷  x  129)  except 
for the region ofGv-1, which governs the G~x phenotype, yet it produces no aG~x 536  AUTOIMMUNITY  TO  GIX  ANTIGEN 
TABLE  II 
Assay for G~x Antibody in the Serum of Mice of Various Inbred 
Strains and Hybrid Stocks* 
Inbred and hybrid mouse stocks 
No. of mice (~ ~ ages 4-6 mo) 
with natural G,× antibody: 
-$  +  ++  +++ 
The G,x Quartet 
129  16 
129-  9 
B6  9 
B6 ÷  20 
Quartet hybrids 
B6  + x  129  6 
B6 ×  129  15 
B6 ×  129-  24 
129 ×  129-  10 
G,x mutant and companion strains 
B6 (see above)  9 
B6-G,x+M  1 
BR  16 
BR-G,x+M  6 
Other hybrids with 129 
BALB/c ×  129  9 
Other inbred G,×  + strains 
AKR,  AKR-H-2  b,  C58,  A,  SJL/J,  31§ 
DBA/2, C3H/An 
Other Inbred G,x  Strains 
C57L, BALB/c, GR  12§ 
Hybrids with AKR 
B6 x  AKR  6 
C57L × AKR  5 
13  12  45 
6  3  3 
5  5  1 
3  2 
* Most G~x  + strains fall into three categories (G~x  3, G~x  ~, and G~x ~) accord- 
ing to the amount of Gix their thymocytes express (see Table II of 
reference 4); for example, 129 is Glx  :*, AKR is Glx  2, and C3H/An is GIxL 
For calculation of (-) to  (+++)  grades, see legend to Fig.  1.  The 
grades indicate Glx-specific  lysis of thymocytes, at  1:8 dilution, as 
follows:  -,  <15%;  +,  15-50%;  ++,  50-75%;  +++,  >75%  (50% end 
point titer 1:32 to 1:64). 
§ Minimum four mice, maximum six mice, of each strain. 
antibody.  Therefore  the  essential  immunogen  causing  autoimmunization  is 
endogenous G~x antigen.  The hybrid  (B6  x  129) should carry the same  comple- 
ment of Ir alleles, and it expresses G,x, though in half the amount  because only 
the  129 parent  is G,x  +.  Autoimmunization  might  therefore be expected,  and  it 
occurs  (Table  II),  although  somewhat  later  than  in Gv-l-homozygous  (B6 +  x 
129)  hybrids,  presumably  because  the  amount  of G,x  autoantigen  is  halved. 
Ultimately  the  levels  of  aG,x  antibody  are  as  high  (data  not  shown).  The 
expectation for the hybrid (B6 +  x  129-) is that it should resemble the hybrid (B6 
x  129)  in  aG,  x  antibody  production.  Our  data  so  far  indicate  that  this  is  so. 
Finally, a basic genetic interpretation  requires that the reciprocal hybrid (129  x 
B6 ÷) should resemble  the  (B6 +  x  129)  hybrid on which  most of the  study was 
based.  This too is the trend of data  now being collected. OBATA  ET  AL.  537 
So far we have found only two other stocks that spontaneously produce aG~x 
antibody, B6-G~x+M and BR-Gxx+M, which originated as spontaneous mutations 
from G~x- to  G~x  ÷ in  B6 and  C57BR (BR), respectively (5).  There  is no ready 
explanation  of why these two stocks should produce aG~x, especially since the 
B6  ÷ congenic mouse does not make  aG~x. Evidently  B6 is not a  total  nonre- 
spender, despite the lack of autoimmunization  in B6  ÷ congenic mice. 
H.  Group-specific  (gs)  Specificity  of the F1 Serum  in Immunoprecipitation 
Tests with Lysed Cells.  Antibody to gs antigen of gp70 occurs in some mouse 
sera  (12,  13),  but has  been  tested  only against  viral  gp70,  not against  gp70 
occurring in the thymocyte plasma membrane without production of virus. Such 
ags-gp70 antiserum, produced by rabbits or goats immunized with purified gp70 
from mouse virus of the FMR type, has little activity against Glx + thymocytes in 
the cytotoxicity assay because the reactive gs antigen is relatively inaccessible 
(2, 14). Such antisera can partially block the reaction of aG~x with G~x  + thymo- 
cytes and so presumably react to some extent with gp70 in the plasma mem- 
brane (1). No doubt "gs antigen" comprises a set of determinants, some partially 
buried in the membrane,  and others which are completely inaccessible unless 
the membrane is first disrupted as in the RIP-lactoperoxidase method. 
The  G~x  quartet  is  ideal  for  detecting  ags-gp70  antibody  by this  method, 
because the four members differ in regard to two gp70 molecules, 0-gp70 and G~x- 
gp70,  where  expression  is  governed  by  separate  unlinked  genes.  The  four 
phenotypes  are  0-gp70  [B6];  0-gp70  and  G~x-gp70 [B6÷];  G~x-gp70 [129];  and 
neither [129-] (14). We have tested the F1 serum with the thymocytes of all four 
strains by the RIP-lactoperoxidase method. All except 129- gave the characteris- 
tic gp70 peak in SDS-PAGE.  The positive reaction of B6 signifies that the F1 
serum  recognizes  0-gp70,  and  so must  include  a  second  antibody  (ags)  with 
broader specificity than  aG~x. 
Pooled sera from the two parental strains,  B6  ÷ and 129 (donors aged >6 mo), 
gave no reaction for gp70 in the same test system, nor did pooled sera from B6, 
129-, or (B6  ×  129-) mice. This does not exclude that a  few individual mice of 
these genotypes might have ags-gp70 antibody which was too diluted by pooling 
to be detectable, but unquestionably the high gs antibody of the hybrid is not 
typical of either parent stock. 
III.  Spontaneous Antigenic Modulation In Vivo.  Ever since antigenic mod- 
ulation was first discovered in the thymus leukemia (TL) system (15,  16), there 
has been much interest in its possible role in disease. Preimmunization against 
TL does not protect TL-  mice from challenge  with syngeneic TL  ÷ leukemias. 
This is the classical instance in which antigenic modulation allows malignant 
cells to escape destruction by an immune response. 
Spontaneous immunization to Gross cell surface antigen (GCSA) occurs natu- 
rally in the B6 strain (17), and high levels of aGCSA antibody can be induced by 
deliberate immunization of B6 mice (18). But this confers little if any protection 
against GCSA  ÷ leukemic transplants,  evidently because GCSA is modulated by 
aGCSA antibody (19). 
On the other hand, administration of specific antiserum can confer protection 
against  transplants  of leukemias  induced  by  Gross  virus  (20)  and  against 
transplants  of X. 1  + leukemias (21).  In these instances malignant cells are not 
protected by antigenic modulation. -
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Clearly the extent and effects of antigenic modulation vary in different tumor- 
associated systems. Regarding cancer,  antigenic modulation can only be harm- 
ful to the host,  and the examples of TL and GCSA suggest that indeed it may 
well be detrimental under natural conditions.  But the situation  is different in 
the  case  of immune  responses  that  are  potentially  pathological  rather  than 
protective, as in diseases caused by or involving autoimmunization.  Here anti- 
genic modulation should be beneficial, and the possibility of antigenic modula- 
tion of G~x in autoimmune hybrids can be viewed in that light. We have studied 
the thymocytes of the  (B6 +  ×  129) hybrids,  at ages from 1 to  14 mo, and have 
found that the progressive rise in spontaneous G~x antibody with age is accompa- 
nied  by decreased expression  of Gxx antigen  (Table III). In general,  the  more 
aG~x antibody there is in the serum, the lower the quantity of G~x demonstrable 
on thymocytes. The thymocytes of four hybrids, ages 6,  10,  14,  and 14 mo, were 
completely negative for G~x antigen  (Table III). 
An alternative explanation for loss of the  G~x phenotype from thymocytes of 
hybrids  making  G~x  antibody  is  that  G~x  ÷  cells  were  destroyed,  leaving  only 
medullary  thymocytes which  characteristically  have  little  or no  G~x antigen. 
There was no obvious change  in the size or cellularity of the thymus,  but the 
more direct evidence against elimination of G~x  + cells is that the thymocytes of 
the hybrids showed no significant deviation in expression of TL and H-2 anti- 
gens (Table III) nor of Thy-1 and Ly antigens (data not given). Thus the thymic 
cell population of autoimmune hybrids has the usual antigen profile of the major 
cortical population,  not that of the  minor medullary population  which  has no 
TL, much less Thy-1, and much more H-2. 
IV.  Other Autoimmune  Phenomena  in  the  Hybrid.  From  section  III  we 
infer that antigenic modulation may prevent the destruction or impaired func- 
tion  of G~x  +  thymocytes.  This  raises  the  question  to  what  extent  antigenic 
modulation  may be beneficial in autoimmune states generally:  We have some 
evidence  that  the  hybrids  do  not  escape  unscathed.  We  have  observed  pro- 
nounced  splenomegaly,  evidently  nonleukemic  because  syngeneic  passage  of 
cells from the enlarged spleen does not yield transplantable leukemia, and also 
histological lesions in the male reproductive tract where large amounts of G~x- 
gp70  are  normally  secreted  (reference  22,  and  personal  unpublished  observa- 
tions).  Neither sign has so far been seen in age-matched  (B6  ×  129-) controls. 
Thus the hybrids are liable to a pathological autoimmune syndrome and are not 
completely protected by antigenic  modulation. 
§ Ratio of CI for thymocytes of mouse  being tested to CI for control  thymocytes. The control 
thymocytes in each system were from comparable mice of strains not exhibiting spontaneous G,x 
antibody production, e.g., B6  ÷ in the case of the Gtx system. The variation in readings for TL and 
H-2 is not more than is to be expected from fluctuations in the relative proportions of TL+:H-2  - 
low (cortical) and TL-:H-2-high  (medullary)  members of the thymocyte population  (16). 
II Procedure~ Step  1;  each  mouse's serum was  absorbed with  BALB/c thymocytes to  remove 
thymocyte autoantibody of unknown specificity (7, 8). Step 2; cytotexicity assay (titration) of the 
absorbed serum on B6 and B6  ÷ thymocytes (in no case was there any reaction with B6). "End 
point" = dilution nearest to a 50% fall in CI below the CI of serum at 1:4 dilution  (0 = CI < 0.5 at 
1:4). "Lysis" = percentage of B6* thymocytes lysed by serum at 1:4 dilution (CI x  100). 
¶ Not tested. 540  AUTOIMMUNITY  TO  Glx  ANTIGEN 
At least a part of the florid autoimmune syndrome of the NZB mouse and its 
hybrids has  been ascribed to reactions  against  the  C-type RNA virus which 
these mice produce in abundance (23). The autoimmurie  (B6  + x  129) hybrid, on 
the other hand,  expresses only certain virus components, notably G~x-gp70. For 
this reason, future details of the autoimmune syndrome of the hybrid should be 
of special interest in revealing the consequences of autoimmunization  against a 
single C-type virus component  (perhaps more than one, but not the complete 
viral  set),  in  a  mouse  with  no  underlying  genetic  abnormality  that  would 
predispose to such disease in the absence of that antigen; the latter follows from 
the  fact that  the  control  (B6  ×  129-)  hybrids have  so far shown no  signs  of 
disease. It is true that electron microscopy of the (B6  ÷ x  129) hybrid shows small 
amounts of virus, but not more than are found in B6  ÷ (electron microscope study 
kindly conducted by Dr. Gloria Koo, Memorial Sloan-Kettering Cancer Center, 
New York) and in several other mouse strains (5). So there is no obvious reason 
to think that the auteimmunity we describe depends on the production of com- 
plete virus. 
V. Ig Class of the Glx Autoantibody.  To determine the Ig class of the Gix 
autoantibody,  a  pool of F~  serum was collected from  >20 hybrids selected for 
high  aGix  activity  in  the  cytotoxicity  assay.  Filtration  of this  serum  pool 
through Sephadex G200 suggested that the aG~x activity was in the macroglobu- 
lin fraction  (mol wt >600,000)  with no demonstrable  activity in the fractions 
with low molecular weight (mol wt <200,000).  Selective elimination of IgM by 
affinity chromatography confirmed this; aG~x activity was thereby reduced to a 
negligible  level.  Evidently,  the  G~x  autoantibody belongs mainly to the  IgM 
class. 
Summary 
The Gix antigen  expressed on the thymocytes of G~x + mice is a  type-specific 
constituent of glycoprotein gp70, which forms the major envelope component of 
murine leukemia virus.  In the prototype G~x  + mouse strain  129, this glycopro- 
tein is a  Mendelian character expressed independently of virus production.  In 
the  intact  thymocyte  plasma  membrane,  part  of this  glycoprotein,  bearing 
group-specific (gs) antigen,  is inaccessible to antibody. The moiety bearing the 
type-specific G~x determinant  is accessible to G~x  antibody,  which may be an 
important  factor  in  determining  the  consequences  of autoimmune  responses 
involving G~x. 
Previously, all attempts to induce G~x antibody in mice had failed.  We now 
find that the hybrid mouse (B6-G~x  + ×  129) spontaneously produces substantial 
amounts of G~x antibody, presumably of the IgM class appearing as early as 2 mo 
of age.  The specificity of the  G~x natural  mouse antibody is the same as that 
recognized by the conventional G~x typing serum produced in rats Canti-NTD"). 
As neither  parent  strain  produces appreciable  G~x antibody,  we surmise  that 
this autoimmune response requires two dominant genes, each parent contribut- 
ing a high-response allele to the hybrid. These can be envisaged as two immune 
response loci, controlling different immunocompetent cells which must cooper- 
ate to produce G~x antibody. OBATA  ET  AL.  541 
Production  of G~× antibody by the hybrids increases progressively with age. 
This is accompanied by decreased expression of G~x antigen on their thymocytes. 
We attribute this to antigenic modulation. 
Antibody to gs antigen of gp70 is also found in autoimmune  (B6-G~x +  ×  129) 
hybrids but not in either parent strain. 
We  are  investigating  evidence  of a  pathological  autoimmune  syndrome  in 
these  hybrids.  The  special  interest  of this  syndrome  is  that  it  presumably 
signifies the consequences of autoimmunization to a  single C-type virus compo- 
nent, expressed without significant virus production, in a mouse with no evident 
genetic predisposition to such disease in the absence of that antigen. 
We thank Doctors Lloyd J. Old and Erwin Fleissner for valuable discussions  and review of the 
manuscript; also Mrs. Pratima Patel for excellent technical  assistance. 
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